423735-93-7,MFCD03063772
Catalog No.:AA00C9OE

423735-93-7 | 2-Bromo-N-(3-butanamidophenyl)benzamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$6.00   $4.00
- +
250mg
98%
in stock  
$73.00   $51.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00C9OE
Chemical Name:
2-Bromo-N-(3-butanamidophenyl)benzamide
CAS Number:
423735-93-7
Molecular Formula:
C17H17BrN2O2
Molecular Weight:
361.2331
MDL Number:
MFCD03063772
SMILES:
CCCC(=O)Nc1cccc(c1)NC(=O)c1ccccc1Br
Properties
Computed Properties
 
Complexity:
389  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
5  
XLogP3:
3.5  

Upstream Synthesis Route

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

[2]Patent:US9422262,2016,B2,.Locationinpatent:Page/Pagecolumn33;34;35

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

[2]Patent:US9422262,2016,B2,

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Gandhi DM, et al. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells. Bioorg Med Chem. 2018 May 15;26(9):2514-2529.

Title: Susanna F Gunnink, et al. Allosteric inhibition of protease activated receptor 1: a new antiplatelet therapy.

Title: Aisiku O, et al. Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar. Blood. 2015 Mar 19;125(12):1976-85.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:423735-93-7 Molecular Formula|423735-93-7 MDL|423735-93-7 SMILES|423735-93-7 2-Bromo-N-(3-butanamidophenyl)benzamide
Catalog No.: AA00C9OE
423735-93-7,MFCD03063772
423735-93-7 | 2-Bromo-N-(3-butanamidophenyl)benzamide
Pack Size: 1mg
Purity: 98%
in stock
$6.00 $4.00
Pack Size: 250mg
Purity: 98%
in stock
$73.00 $51.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00C9OE
Chemical Name: 2-Bromo-N-(3-butanamidophenyl)benzamide
CAS Number: 423735-93-7
Molecular Formula: C17H17BrN2O2
Molecular Weight: 361.2331
MDL Number: MFCD03063772
SMILES: CCCC(=O)Nc1cccc(c1)NC(=O)c1ccccc1Br
Properties
Complexity: 389  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 22  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 5  
XLogP3: 3.5  
Upstream Synthesis Route
93469-29-5    88-65-3    423735-93-7 

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

[2]Patent:US9422262,2016,B2,.Locationinpatent:Page/Pagecolumn33;34;35

99-09-2    423735-93-7 

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

[2]Patent:US9422262,2016,B2,

107829-09-4    423735-93-7 

[1]ACSMedicinalChemistryLetters,2012,vol.3,#3,p.232-237

Literature fold

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Gandhi DM, et al. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells. Bioorg Med Chem. 2018 May 15;26(9):2514-2529.

Title: Susanna F Gunnink, et al. Allosteric inhibition of protease activated receptor 1: a new antiplatelet therapy.

Title: Aisiku O, et al. Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar. Blood. 2015 Mar 19;125(12):1976-85.

Building Blocks More >
423724-45-2
423724-45-2
3-[(2-Fluorobenzyl)oxy]benzaldehyde
AA00C9V6 | MFCD01590570
321436-06-0
321436-06-0
7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one
AA00CA5O | MFCD00798619
40640-97-9
40640-97-9
Ethyl 3-(3-bromophenyl)propanoate
AA00CADE | MFCD09028773
338982-44-8
338982-44-8
5-Fluoro-2-(4-fluorobenzoyl)benzenecarboxylic acid
AA00CASW | MFCD01935981
22649-27-0
22649-27-0
3-Chloro-5,7-dihydroxy-4-methyl-2h-chromen-2-one
AA00CBW0 | MFCD00488345
28114-90-1
28114-90-1
6-(Ethoxycarbonyl)spiro[3.3]heptane-2-carboxylic acid
AA00CELQ | MFCD22419340
243644-28-2
243644-28-2
2-[4-(tert-Butyl)phenyl]-5-(2-chloro-5-nitrophenyl)-1,3,4-oxadiazole
AA00CGK6 | MFCD00117794
37934-89-7
37934-89-7
2,6-Dimethyl-4-methoxybenzoic acid
AA00CH9X | MFCD01194287
3557-90-2
3557-90-2
H-Lys(4-nitro-z)-oh
AA00CHO5 | MFCD00237145
4201-62-1
4201-62-1
N-[(1S,2R,3E)-1-[(4-O-β-D-Galactopyranosyl-β-D-glucopyranosyl)oxymethyl]-2-hydroxy-3-heptadecenyl]hexadecanamide
AA00CIJK | MFCD28789016
Submit
© 2017 AA BLOCKS, INC. All rights reserved.